EBioMedicine (Oct 2024)

Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancerResearch in context

  • Alexia Mirandola,
  • Andrei Kudriavtsev,
  • Catalina Isabel Cofre Muñoz,
  • Raquel Comas Navarro,
  • Marco Macagno,
  • Saidi Daoud,
  • Cynthia Sanchez,
  • Brice Pastor,
  • Ekaterina Pisareva,
  • Mireia Sanchis Marin,
  • Javier Gonzalo Ruiz,
  • Alejandro Piris,
  • Ariadna Garcia Rodriguez,
  • Nadia Saoudi Gonzalez,
  • Ana Vivancos,
  • Virginia Quarà,
  • Alfredo Mellano,
  • Felice Borghi,
  • Giorgio Corti,
  • Caterina Marchiò,
  • Anna Sapino,
  • Alice Bartolini,
  • Giovanni Crisafulli,
  • Alberto Bardelli,
  • Massimo Di Maio,
  • Gerald Lossaint,
  • Florence Frayssinoux,
  • Evelyne Crapez,
  • Marc Ychou,
  • Ramon Salazar Soler,
  • Elisabetta Fenocchio,
  • Paula X. Fernandez Calotti,
  • Thibault Mazard,
  • Cristina Santos Vivas,
  • Elena Elez,
  • Federica Di Nicolantonio,
  • Alain R. Thierry

Journal volume & issue
Vol. 108
p. 105352

Abstract

Read online

Summary: Background: We studied the poorly-known dynamics of circulating DNA (cir-nDNA), as monitored prospectively over an extended post-surgery period, in patients with cancer. Methods: On patients with stage III colon cancer (N = 120), using personalised molecular tags we carried out the prospective, multicenter, blinded cohort study of the post-surgery serial analysis of cir-nDNA concentration. 74 patients were included and 357 plasma samples tested. Findings: During post-operative follow-up, the patients’ median cir-nDNA concentration was greater (P 18 months post-surgery, the data suggest that the persistence of NETs formation is not due to the adjuvant CT. Interpretation: (1), Given the inter-patient heterogeneity, the post-surgery cir-nDNA level cannot be considered a reliable value, and caution must be exercised when determining mutation allele frequency or the mutation status; and (2), specific studies must be undertaken to investigate the possible clinical impact of the persistent, low-grade inflammation resulting from elevated NETs levels, such as observed in these post-surgery patients, given that such levels are known to potentially induce adverse cardiovascular or thrombotic events. Funding: This work was supported by the H2020 European ERA-NET grant on Translational Cancer Research (TRANSCAN-2).

Keywords